Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ADAP - Adaptimmune: How The Story Is Shaping Up For The Latter Half Of 2024

ADAP - Adaptimmune: How The Story Is Shaping Up For The Latter Half Of 2024

Adaptimmune Therapeutics plc

2024-07-03 09:54:32 ET

Summary

  • Adaptimmune Therapeutics is focused on late-stage development of cell therapy for cancer, particularly in sarcoma management.
  • Pipeline updates include progress on afami-cel for soft tissue sarcomas and lete-cel for synovial sarcoma.
  • Financially, ADAP has a cash runway of around 3 quarters, with potential resources from collaborations and agreements extending it further.

Topline Summary and Update

For further details see:

Adaptimmune: How The Story Is Shaping Up For The Latter Half Of 2024
Stock Information
Company Name: Adaptimmune Therapeutics plc
Stock Symbol: ADAP
Market: NASDAQ
Website: adaptimmune.com
Menu
ADAP ADAP Quote ADAP Short ADAP News ADAP Articles ADAP Message Board
Get ADAP Alerts

News, Short Squeeze, Breakout and More Instantly...